Global Humira 麻豆原创 Growth 2024-2030

Publication ID:

LPI01244294

Publication Date:

January 11, 2024

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a readjusted size of US$ 8891.4 million by 2030 with a CAGR of -8.6% during review period.
The research report highlights the growth potential of the global Humira market. Humira are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Humira. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Humira market.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn鈥檚 disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
麻豆原创 competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
Key Features:
The report on Humira market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Humira market. It may include historical data, market segmentation by Type (e.g., Humira Syringe, Humira Pen), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Humira market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Humira market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Humira industry. This include advancements in Humira technology, Humira new entrants, Humira new investment, and other innovations that are shaping the future of Humira.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Humira market. It includes factors influencing customer ' purchasing decisions, preferences for Humira product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Humira market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Humira market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Humira market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Humira industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Humira market.
麻豆原创 Segmentation:
Humira market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Humira Syringe
Humira Pen
Segmentation by application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn鈥檚 Disease
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Eisai
Cadila Healthcare
Amgen
Boehringer Ingelheim
Samsung Bioepis
Biocon
Fresenius Kabi
Celltrion
Coherus
Sandoz
Torrent Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Humira market?
What factors are driving Humira market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humira market opportunities vary by end market size?
How does Humira break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Humira Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Humira by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Humira by Country/Region, 2019, 2023 & 2030
2.2 Humira Segment by Type
2.2.1 Humira Syringe
2.2.2 Humira Pen
2.3 Humira Sales by Type
2.3.1 Global Humira Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Humira Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Humira Sale Price by Type (2019-2024)
2.4 Humira Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Rheumatoid Arthritis
2.4.3 Crohn鈥檚 Disease
2.4.4 Others
2.5 Humira Sales by Application
2.5.1 Global Humira Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Humira Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Humira Sale Price by Application (2019-2024)
3 Global Humira by Company
3.1 Global Humira Breakdown Data by Company
3.1.1 Global Humira Annual Sales by Company (2019-2024)
3.1.2 Global Humira Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Humira Annual Revenue by Company (2019-2024)
3.2.1 Global Humira Revenue by Company (2019-2024)
3.2.2 Global Humira Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Humira Sale Price by Company
3.4 Key Manufacturers Humira Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humira Product Location Distribution
3.4.2 Players Humira Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Humira by Geographic Region
4.1 World Historic Humira 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Humira Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Humira Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Humira 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Humira Annual Sales by Country/Region (2019-2024)
4.2.2 Global Humira Annual Revenue by Country/Region (2019-2024)
4.3 Americas Humira Sales Growth
4.4 APAC Humira Sales Growth
4.5 Europe Humira Sales Growth
4.6 Middle East & Africa Humira Sales Growth
5 Americas
5.1 Americas Humira Sales by Country
5.1.1 Americas Humira Sales by Country (2019-2024)
5.1.2 Americas Humira Revenue by Country (2019-2024)
5.2 Americas Humira Sales by Type
5.3 Americas Humira Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humira Sales by Region
6.1.1 APAC Humira Sales by Region (2019-2024)
6.1.2 APAC Humira Revenue by Region (2019-2024)
6.2 APAC Humira Sales by Type
6.3 APAC Humira Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Humira by Country
7.1.1 Europe Humira Sales by Country (2019-2024)
7.1.2 Europe Humira Revenue by Country (2019-2024)
7.2 Europe Humira Sales by Type
7.3 Europe Humira Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Humira by Country
8.1.1 Middle East & Africa Humira Sales by Country (2019-2024)
8.1.2 Middle East & Africa Humira Revenue by Country (2019-2024)
8.2 Middle East & Africa Humira Sales by Type
8.3 Middle East & Africa Humira Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
10.4 Industry Chain Structure of Humira
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humira Distributors
11.3 Humira Customer
12 World Forecast Review for Humira by Geographic Region
12.1 Global Humira 麻豆原创 Size Forecast by Region
12.1.1 Global Humira Forecast by Region (2025-2030)
12.1.2 Global Humira Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Humira Forecast by Type
12.7 Global Humira Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Humira Product Portfolios and Specifications
13.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Humira Product Portfolios and Specifications
13.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Humira Product Portfolios and Specifications
13.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Humira Product Portfolios and Specifications
13.4.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Information
13.5.2 Boehringer Ingelheim Humira Product Portfolios and Specifications
13.5.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boehringer Ingelheim Main Business Overview
13.5.5 Boehringer Ingelheim Latest Developments
13.6 Samsung Bioepis
13.6.1 Samsung Bioepis Company Information
13.6.2 Samsung Bioepis Humira Product Portfolios and Specifications
13.6.3 Samsung Bioepis Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Samsung Bioepis Main Business Overview
13.6.5 Samsung Bioepis Latest Developments
13.7 Biocon
13.7.1 Biocon Company Information
13.7.2 Biocon Humira Product Portfolios and Specifications
13.7.3 Biocon Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biocon Main Business Overview
13.7.5 Biocon Latest Developments
13.8 Fresenius Kabi
13.8.1 Fresenius Kabi Company Information
13.8.2 Fresenius Kabi Humira Product Portfolios and Specifications
13.8.3 Fresenius Kabi Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Fresenius Kabi Main Business Overview
13.8.5 Fresenius Kabi Latest Developments
13.9 Celltrion
13.9.1 Celltrion Company Information
13.9.2 Celltrion Humira Product Portfolios and Specifications
13.9.3 Celltrion Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Celltrion Main Business Overview
13.9.5 Celltrion Latest Developments
13.10 Coherus
13.10.1 Coherus Company Information
13.10.2 Coherus Humira Product Portfolios and Specifications
13.10.3 Coherus Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Coherus Main Business Overview
13.10.5 Coherus Latest Developments
13.11 Sandoz
13.11.1 Sandoz Company Information
13.11.2 Sandoz Humira Product Portfolios and Specifications
13.11.3 Sandoz Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sandoz Main Business Overview
13.11.5 Sandoz Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Humira Product Portfolios and Specifications
13.12.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.